The role of add-on devices and how they affect drug delivery with a pressurized metered dose inhaler.
Mark Copley
Advertisement
Mark Copley is Sales Director at Copley Scientific.
Articles by Mark Copley
Even in an industry in which all product development is complicated by the intricacies of human biology, orally inhaled products (OIP) stand out as singularly demanding.
Advertisement
Latest Updated Articles
Improving Inhaled Product Testing: Methods for Obtaining Better In vitro-In vivo RelationshipsPublished: February 2nd 2013 | Updated:
Exploring Newly Introduced Methods for Testing MDIs with Add-On DevicesPublished: September 2nd 2014 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
2
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
3
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
4
PharmTech Weekly News Roundup – Week of November 3, 2025
5
